Chimerix 2Q21 Corporate Presentation Forward-Looking Statements 2 These slides contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include those relating to, among other things, Chimerix's ability to develop and commercialize its drug candidates including ONC201, DSTAT and TEMBXA®; the sufficiency of the da ...